In today’s recent session, 1.75 million shares of the Merck & Co Inc (NYSE:MRK) have been traded, and its beta is 0.40. Most recently the company’s share price was $97.91, and it changed around $1.37 or 1.42% from the last close, which brings the market valuation of the company to $247.68B. MRK at last check was trading at a discount to its 52-week high of $134.63, offering almost -37.5% off that amount. The share price’s 52-week low was $94.48, which indicates that the recent value has risen by an impressive 3.5% since then. We note from Merck & Co Inc’s average daily trading volume that its 10-day average is 11.1 million shares, with the 3-month average coming to 9.57 million.
Merck & Co Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.63. If we narrow it down even further, the data shows that 0 out of 34 analysts rate the stock as a Sell; another 7 rate it as Overweight. Among the rest, 10 recommended MRK as a Hold, whereas 17 deemed it a Buy, and 0 rated it as Underweight. Merck & Co Inc is expected to report earnings per share of 1.84 for the current quarter.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Merck & Co Inc (NYSE:MRK) trade information
Instantly MRK has been showing a green trend so far today with a performance of 1.42% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 99.40 on recent trading dayincreased the stock’s daily price by 1.5%. The company’s shares are currently down -10.19% year-to-date, but still down -0.60% over the last five days. On the other hand, Merck & Co Inc (NYSE:MRK) is -8.19% down in the 30-day period. We can see from the shorts that 26.23 million shares have been sold at a short interest cover period of 2.75 day(s).
The consensus price target as assigned by Wall Street analysts is $132, which translates to bulls needing to increase their stock price by 25.83% from its current value. Analyst projections state that MRK is forecast to be at a low of $80 and a high of $294.
Merck & Co Inc (MRK) estimates and forecasts
Merck & Co Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -25.32 percent over the past six months and at a 411.26% annual growth rate that is well above the industry average of 9.00%. Moreover, analysts have decided to roll up on their fiscal year 2024 revenue estimates. The rating firms predict that it will gain 6,044.67% in revenue this quarter, and will report an increase of 11.20% in the next quarter. The year-over-year growth rate is expected to be 6.63%, up from the previous year.
Consensus estimates provided by 17 financial analysts predict the company will bring in an average of 15.56B in revenue for the current quarter. 3 analysts expect Merck & Co Inc to make 16.59B in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 14.63B and 15.78B respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 6.37%. Forecasts for the next quarter put sales growth at 5.15%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -42.70%. Merck & Co Inc earnings are expected to increase by 412.31% in 2024, but the outlook is positive 23.85% per year for the next five years.
MRK Dividends
Merck & Co Inc’s next quarterly earnings report is expected to be released in December. The annual dividend yield of the stock is 3.15 percent and its annual dividend per share was 3.08. It is important to note, however, that the 3.15% dividend yield ratio should be regarded as a guide only, as many other factors should be taken into consideration before making any investment decision. The average dividend yield for the past five years averaged 2.9 per year.
Merck & Co Inc (NYSE:MRK)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.06% of Merck & Co Inc shares, and 79.37% of them are in the hands of institutional investors. The stock currently has a share float of 79.42%. Merck & Co Inc stock is held by 4378.0 institutions, with VANGUARD GROUP INC being the largest institutional investor. By 2024-06-30, it held 9.6596% of the shares, which is about 244.68 million shares worth $30.29 billion.
BLACKROCK INC., with 8.1838% or 207.3 million shares worth $25.66 billion as of 2024-06-30, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund were the top two Mutual Funds as of Jun 30, 2024. The former held 80.02 shares worth $7.85 billion, making up 3.16% of all outstanding shares. On the other hand, Vanguard 500 Index Fund held roughly 65.01 shares worth around $6.38 billion, which represents about 2.57% of the total shares outstanding.
